BAP31 deficiency contributes to the formation of amyloid-β plaques in Alzheimer’s disease by reducing the stability of RTN3
BAP31 deficiency contributes to the formation of amyloid-β plaques in Alzheimer’s disease by reducing the stability of RTN3
复制标题
BAP31 缺陷通过降低 RTN3 的稳定性,导致阿尔茨海默病中淀粉样β斑块的形成
DOI:
10.1096/fj.201801702r
复制
发表时间:
--
期刊:
影响因子:
--
通讯作者:
Tianyi Wang
中科院分区:
文献类型:
--
作者:
Tianyi Wang
Reticulon 3 (RTN3) reduces amyloid-β plaques (APs) by negatively modulating of β-secretase 1 (BACE1) activity. However, RTN3 aggregates easily, which offsets RTN3’s inhibitory effect on BACE1 activity and exacerbates AP deposition. We found that BAP31 was a binding partner of RTN3 and positively correlated with the expression level of RTN3. To further explore how BAP31 is involved in Alzheimer’s disease (AD), conditional knockout mice with targeted BAP31 deletion (B-KO) in the hippocampus and cerebral cortex were generated and hybridized with APP/PS1 transgenic (AD model) mice to obtain B-KO-AD mice. BAP31 knockout in primary hippocampal neurons decreased RTN3 monomer availability and enhanced the level of RTN3 aggregates, indicating that BAP31 deficiency increases the instability of RTN3. More importantly, these effects contributed to BACE1-mediated amyloid precursor protein (APP) processing, and were responsible for the increased APs in the hippocampus and cerebral cortex of B-KO-AD mice. Thus, elevated expression of BAP31 in the human brain is likely to reduce the formation of both RTN3 aggregates and amyloid-β (Aβ) by enhancing the stability of RTN3..